RBM3 and urinary bladder cancer: A clinical retrospective study including 259 bladder cancer patients showed that the low expression of RBM3 was an independent factor for poor prognosis of bladder cancer [39]; this finding is closely related to the progression of bladder cancer and decreased overall survival of patients [40].